Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Effective date: December 17, 2025

General Privacy Policy 

This Privacy Policy describes how Powerful Medical Inc., including its affiliates, collects, uses and discloses data, and what your rights are in relation to the data. When we refer to “PM”, we refer to Powerful Medical Inc. or as may be applicable any of its affiliates who process personal data, in particular POWERFUL MEDICAL s.r.o. with registered seat at Karadžičova 8/A Bratislava – mestská časť Ružinov 821 08, the Slovak Republic, Company lD No.: 50 948 431, registered with the Commercial Register of the Municipal Court Bratislava III, Section: Sro; Insert No.: 184319/B.

Applicability

This Privacy Policy applies to PM’s services, subscription services, including the associated PM mobile application, PM web platform and PM service account utilizing API (collectively, the “Services”), www.powerfulmedical.com and other PM’s websites (collectively, the “Websites”) and other interactions (e.g., customer service inquiries, user conferences, etc.) you might have with PM.

If you do not agree with the terms of this Privacy Policy, do not access or use the Services, Websites or any other aspect of PM’s business.

This Privacy Policy does not apply to any third party applications or software that integrate with the Services through the Services (“Third Party Services”), or any other third party products, services or businesses.

In addition, a separate agreement governs delivery, access and use of the Services (the “Customer Agreement”), including the processing of any messages, files or other content submitted through use of the Services or in connection with the Services (collectively, “Personal Data”) and the Services are provided on the basis of an End User Licence Agreement which everyone who uses our Services (“User”) must enter into (the “EULA”). The organization (e.g., your employer or another entity or person) that entered into the Customer Agreement (“Customer”) controls certain aspects of their instance of the Services (their “Deployment”) and associated Personal Data, for example, how long PM will retain Personal Data, subject to terms and conditions of the Customer Agreement.

To the extent any information we process is associated with an identified or identifiable natural person and is protected as personal data under applicable data protection law, it is referred to in this Privacy Policy as “Personal Data.” You are under no statutory obligation to provide any Personal Data. However, certain information is collected automatically and, if some information, such as contact information, is not provided, PM may be unable to provide the Services.

This Privacy Policy applies to all data subjects, including those who fall under the jurisdiction of the Regulation (EU) 2016/679 of the European Parliament and of the Council on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation) (“GDPR”) and those who fall under similar U.S. regulations such as the in the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”). Depending on your location and the applicable law, either GDPR or relevant U.S. privacy laws will govern our handling of your personal data.

Specifically, any reference to the GDPR within this policy is applicable solely to Users who fall under its jurisdiction. For U.S. residents, particularly those whose data is regulated under HIPAA or other relevant U.S. laws, our practices will adhere to those specific regulations.

Health Information

Within the Services the User scans ECG recordings of individuals selected by the User (patients) uploads the image to our severs, where our AI algorithms digitize, analyze, and interpret the ECG recording for further analysis. Based on the ECG analysis, disease-specific patient history questions are generated. Upon answering the User is provided with a patient management recommendation. Personal Data may in some instances include “Protected Health Information” as defined in the HIPAA or Article 4 (15) of the GDPR. Protected Health Information is governed either by the HIPAA Business Associate Agreement or by the GDPR Data Processing Agreement between the Customer and PM and not by this Privacy Policy.

Protected Health Information is governed either by the HIPAA Business Associate Agreement or by the GDPR Data Protection Agreement between the Customer and PM and not by this Privacy Policy.

How We Use Personal Data

Personal Data will be used by PM in accordance with applicable terms in the Customer Agreement, the EULA and Customer’s use of Services functionality, and as required by applicable law. PM primarily acts as a processor of Personal Data and the Customer acts as the controller, unless stated otherwise in this Privacy Policy. Customer may, for example, use the Services to grant and remove access to an authorized user, assign roles and configure settings, access, modify, export, share and remove Personal Data and otherwise apply its policies to the Services. For details on specific roles, please refer to Section ‘Processing of Personal Data’.

PM uses certain Personal Data in furtherance of our legitimate interests in operating our Services, Websites and overall business.

If Personal Data is aggregated or de-identified so it is no longer reasonably associated with an identified or identifiable natural person, PM may use it for any business purpose.

Processing of Personal Data

We process your Personal Data for the following purposes:

  • Deployment and Account Information. To create or update an authorized User account or a User glossary, you or the Customer (e.g. your employer) supply PM with an email address, phone number, role or title, and other similar account details. In addition, Customers provide PM (or its payment processors) with its own billing details such as banking information and a billing address.
    • Roles: PM acts as a controller.
    • Legal basis: The processing is necessary for the performance of a contract to which the data subject is a party under Article 6(1)(b) of the GDPR, or processing is necessary for the purpose of legitimate interest under Article 6(1)(f) of the GDPR of the controller consisting in performance of contractual obligations, regulatory requirements and defence against legal claims. The applicable contract is the Agreement which is concluded between Us and the Customer and the EULA which is concluded between Us and the User
    • Data subjects: The Customer and the User .
    • Retention period: Data is kept until (i) Customer’s account in the Services or the Websites’ account is deleted; (ii) mandatory retention periods are satisfied (e. g. accounting); (iii) in case of other regulatory, legal requirements or litigation, kept until resolution of such requirements or litigation.
  • Operation of the Services. ECG digitization / ECG interpretation consisting of segmentation, analysis and diagnosis; patient management recommendation. During such processing PM may process certain information such as name, surname and contact details of Users, as well as data provided by the User relating to patients, in particular ECG image, sex, age, patient’s personal number (optional), and further data required to determine patient management recommendations.
    • Roles: In relation to this purpose, PM acts as a processor and the Customer acts as a controller. As such, the Customer is accountable for ensuring the provision of appropriate information to the underlying data subject and evidencing the right legal basis (e.g. consent or legal obligation to process personal data).
    • Legal basis: We process personal data on the basis of a data processing agreement concluded between PM and the Customer under Article 28 of the GDPR.
    • Data subjects: Such individuals as the Customer determines – User´s patients and Users.
    • Retention period: Personal data will be retained in line with Customer’s instructions as the data controller. Deletion will be undertaken upon request by the Customer as the data controller.
  • Technical Usage Information. To enhance the efficiency and reliability of the Services’ support and maintenance, PM may process the following data:
  • Usage Information. PM may (a) collect usage data in connection with your use of the Services and the Websites; (b) conduct satisfaction surveys; and (c) use usage data, satisfaction surveys data and your feedback in connection with providing and improving the Services and the Websites.
  • Services Metadata When an Authorized User interacts with the Services, metadata is generated that provides additional context about the way Authorized Users work.
  • Log data. As with most websites and technology services delivered over the Internet, our servers automatically collect information when you access or use our Websites or Services and record it in log files. This log data may include the Internet Protocol (IP) address, the address of the web page visited before using the Websites or Services, browser type and settings, the date and time the Services were used, information about browser configuration and plugins, language preferences and cookie data.
  • Device information. PM information about devices accessing the Services, including for example type of device, what operating system is used, device settings, application IDs, unique device identifiers and crash data. What specific device information we collect depends on the type of device used and its settings.
    • Roles: PM acts as a controller.
    • Legal basis: The processing is necessary for the performance of a contract to which the data subject is a party under Article 6(1)(b) of the GDPR, or processing is necessary for the purpose of legitimate interest under Article 6(1)(f) of the GDPR of the controller consisting in performance of contractual obligations, regulatory requirements and defence against legal claims.
    • Data subjects: The Customer and the User.
    • Retention period: Data is kept until (i) Customer’s account in the Services or Websites’ account is deleted; (ii) in case of other regulatory, legal requirements or litigation, kept until resolution of such requirements or litigation.
  • Location information. To ensure optimizing resource allocation, and facilitating quicker response times in Services we may receive information from you, your Customer and other third-parties that helps us approximate your location. We may, for example, use a business address submitted by your employer, or an IP address received from your browser or device to determine approximate location. PM may also collect location information from devices in accordance with the consent process provided by your device.
    • Roles: PM acts as a controller.
    • Legal basis: The processing of personal data for communication is based on your consent under Article 6(1)(a).
    • Data subjects: User.
    • Retention period: Data is kept until (i) Customer’s account in the Services or Websites’ account is deleted; (ii) in case of other regulatory, legal requirements or litigation, kept until resolution of such requirements or litigation.
  • Cookie Information. PM uses cookies and similar technologies in our Websites and Services that help us collect certain information. The Websites and Services may also include cookies and similar tracking technologies of third parties, which may collect certain information about you via the Websites and Services and across other websites and online services. To help us understand how people interact with PMcardio for Individuals as part of our Services offering and to improve usability, maintenance, and performance, we may use session replay technology (e.g. Amplitude Session Replay). This technology collects information about your interactions in the PMcardio for Individuals app, including actions like clicks, scrolling, page navigation, and other usage patterns. Captured session data may also include technical information such as device type, browser, and performance details, but it does not include sensitive personal information such as passwords, credit card numbers, or health data. The session replay data we collect is used only to analyze and improve the functionality, reliability, and user experience of the Services, and is processed in accordance with applicable law and this Privacy Policy.
    • Roles: PM acts as a controller.
    • Legal basis: The processing of personal data for communication is based on your consent under Article 6(1)(a), unless the processing is necessary for the purpose of legitimate interest under Article 6(1)(f) of the GDPR.
    • Data subjects: The Customer and the User.

For further information on how and what type of cookies we use, please visit our Cookies Policy.

  • Research to further improve the existing technologies. This includes using provided ECG and related health data to improve the used technologies. All of the used data is de-identified and does not allow for identification of the patient and may include ECG image, sex, age, and further data required to determine patient management recommendations.
    • Roles: PM acts as a controller.
    • Legal basis: Legitimate interest of the controller under Article 6(1)(f) and Article 9(2)(j) of the GDPR consisting in research of artificial intelligence. The processing is necessary for further development of the Services, its algorithm and software.
    • Data subjects: Individuals whose data has been uploaded by the User.
    • Retention period: Data is kept in de-identified form for such time as needed to achieve the purpose.
  • Medical device vigilance – Protecting and improving safeguards for patients, Users and others by preventing the likelihood of recurrence of incidents. The data of patients may include ECG image, sex, age, and further data required to determine patient management recommendations; name, surname and occupation of Users.
    • Roles: PM acts as a controller.
    • Legal basis: In accordance with Article 6(1)(c) of the GDPR, processing is necessary for compliance with a legal obligation (EU MDR 2017/745) to which PM is a subject.
    • Data subjects: Users and patients.
    • Retention period: Data is retained during period stipulated by law, which is 10 years.
  • Communication with you – For the purpose of provision of Services PM may communicate with you by responding to your requests, comments and questions. We may also send you service, technical and other administrative emails, messages and other types of communications such as messages via notifications build into the Services. We may also contact you to inform you about changes in our Services such as new features, changes in our offerings, and important Services-related notices (e.g. security and fraud notices). These communications are considered part of the Services and you cannot opt out of them. In addition, we may sometime send you emails about promotional communications or other news about PM.
    • Roles: PM acts as a controller.
    • Legal basis: The processing is necessary for the performance of a contract to which the data subject is a party under Article 6(1)(b) of the GDPR, or processing is necessary for the purpose of legitimate interest under Article 6(1)(f) of the GDPR of the controller consisting in performance of contractual obligations, or based on your consent under Article 6(1)(a) and legitimate interest under Article 6(1)(f) of the GDPR consisting in direct marketing.
    • Retention period: Data is kept until (i) Customer’s account in the Services or Websites’ account is deleted; (ii) in case of other regulatory, legal requirements or litigation, kept until resolution of such requirements or litigation.
  • Third Party Services and Third Party Data – Customer can choose to permit Third Party Services for their Deployment. Typically, Third Party Services are software that integrate with our Services. When enabled, the provider of a Third Party Service may share certain information with PM. For instance, if a cloud storage application is enabled to permit files to be imported to a Deployment, we may receive username and email address of authorized users, along with additional information that the application has elected to make available to PM to facilitate the integration. Authorized Users should check the privacy settings and notices in these Third Party Services to understand what data may be disclosed to PM. When a Third Party Service is enabled, PM is authorized to connect and access certain Personal Data made available to PM in accordance with our agreement with the third party provider. PM may receive data about organizations, industries, Websites visitors, marketing campaigns and other matters related to our business from affiliates, our partners or others that we use to improve our own information. This data may be combined with Personal Data we collect and might include aggregate level data, such as which IP addresses correspond to zip codes or countries. Or in some cases it might be more specific, such as, how well a certain marketing campaign performed.
    • Roles: PM acts as a controller.
    • Legal basis: The processing is necessary for the performance of a contract to which the data subject is a party under Article 6(1)(b) of the GDPR, or processing is necessary for the purpose of legitimate interest under Article 6(1)(f) of the GDPR of the controller consisting in performance of contractual obligations.
    • Retention period: Data is kept until (i) Customer’s account in the Services or Websites’ account is deleted; (ii) in case of other regulatory, legal requirements or litigation, kept until resolution of such requirements or litigation.

Data Retention

PM will retain Personal Data in accordance with a Customer’s instructions, subject to any applicable terms in the Customer Agreement and Customer’s use of Services functionality, and as required by applicable law. Typically, PM will retain Personal Data for the duration of a Customer’s subscription term in the Customer Agreement only for as long as is necessary for the purposes set out in this Privacy Policy. PM may retain certain Personal Data after you have deactivated your account for the period of time needed for PM to pursue legitimate business interests, conduct audits, comply with (and demonstrate compliance with) legal obligations, resolve disputes and enforce our legal contracts.

How We Share and Disclose Information

  • Customer’s Instructions. PM will solely share and disclose Personal Data in accordance with the Customer Agreement, a Customer’s instructions, subject to any applicable terms in the Customer Agreement and Customer’s use of Services functionality, and in compliance with applicable law.
  • Displaying the Services. When an authorized User submits information, it may be displayed to other authorized Users. For example, an authorized User’s account details may be displayed with their Deployment profile in order to use the Services.
  • Customer Access. Authorized Users and other Customer representatives and personnel may be, subject to the Customer Agreement, able to access, modify or restrict access to certain information. This may include, for example, your employer using Service features to see or export logs of your activity, or accessing or modifying your profile details.
  • Third Party Service Providers and Partners. PM may engage third party companies or individuals as service providers or business partners to process Personal Data and support our business.
  • Affiliates. PM may share Personal Data with its corporate affiliates as needed to provide you with the Services in which case PM will require those affiliates to honour this Privacy Policy. Affiliates include our subsidiaries, joint venture partners or other companies that PM controls or that are under common control with PM.
  • PM Change of Control. If PM engages in a merger, acquisition, bankruptcy, dissolution, reorganization, sale of some or all of PM’s assets or stock, financing, public offering of securities, acquisition of all or a portion of PM’s business, a similar transaction or proceeding, or steps in contemplation of such activities (e.g. due diligence), some or all Personal Data may be shared or transferred, subject to market standard confidentiality arrangements.
  • Aggregated or De-identified Data. Subject to the Customer Agreement, we may use or disclose aggregated or de-identified Personal Data for various purposes. For example, we may share aggregated or de-identified Personal Data with prospects or partners for business or research purposes.
  • To Comply with Laws. If we receive a request for information, we may disclose Personal Data if we reasonably believe disclosure is in accordance with or required by any applicable law or other binding regulation or judicial or administrative decision.
  • To enforce our rights, prevent fraud, and for safety. To protect and defend the rights, property or safety of PM and/or third parties, including enforcing contracts or policies, or in connection with investigating and preventing fraud or security issues.
  • With Consent. In addition to the above, PM may share Personal Data with third parties when we have the consent to do so.

Security

PM takes security of data very seriously. PM works hard to protect Personal Data you provide from loss, misuse, and unauthorized access or disclosure. These steps take into account the sensitivity of the Personal Data we collect, process and store, and the current state of technology. To learn more about PM’s commitment to security and various internationally security standards we adhere to, please visit our trust center at: https://trust.powerfulmedical.com/.

Age Limitations

To the extent not prohibited by applicable law, PM does not allow use of our Services and Websites by anyone younger than 16 years old. If you learn that anyone younger than 16 has unlawfully provided us with personal data, please contact us and we will take appropriate steps to delete such information.

Changes to This Privacy Policy

PM may at its discretion change this Privacy Policy from time to time. Laws, regulations and industry standards evolve, which may make those changes necessary, or we may make changes to our business. We will post the changes to this page and encourage you to review our Privacy Policy to stay informed. If you disagree with the changes to this Privacy Policy, you should deactivate your Services account. Contact the Customer if you wish to request the removal of Personal Data under their control.

Data Protection Officer

To communicate with our Data Protection Officer, please email dpo@powerfulmedical.com

Contacting Powerful Medical

Please also feel free to contact PM if you have any questions about this Privacy Policy, our privacy practices, or if you want to exercise any of your statutory rights. You may contact us at legal@powerfulmedical.com or at our mailing address below:

U.S.:
Powerful Medical Inc.
7th floor, 33 West 17th Street
New York, NY, USA

EMEA:
POWERFUL MEDICAL s. r. o.
CBC I, Karadičova 8/A, 821 08,
Bratislava, Slovak Republic

Rights applicable to individuals located in EMEA

If you are located within the EMEA, you may have the following rights:

  1. Request access to your Personal Data. The right to access, update or delete the information We have relating to you. You may also access, update or request deletion of your Personal Data directly within your account settings section. If you are unable to perform these actions yourself, please contact Us to assist you. This also enables you to receive a copy of the Personal Data We hold about you.
  2. Request correction of the Personal Data that We hold about you. You have the right to have any incomplete or inaccurate information We hold about you corrected.
  3. Object to processing of your Personal Data. You may have the right to object if we process Personal Data for direct marketing purposes or based on specific grounds relating to your situation, if we process Personal Data for our legitimate interests listed above.
  4. Request erasure of your Personal Data. You may have the right to ask Us to delete or remove Personal Data, in specific cases outlined under the applicable laws.
  5. Request the transfer of your Personal Data. We will provide to you, or to a third-party you have chosen, your Personal Data in a structured, commonly used, machine-readable format. Please note that this right only applies to automated information which you initially provided consent for Us to use or where We used the information to perform a contract with you.
  6. Withdraw your consent. You have the right to withdraw your consent on using your Personal Data, if such Personal Data was obtained on such legal basis. If you withdraw your consent, we may not be able to provide you with access to certain specific functionalities of the Service.

Exercising of your GDPR Data Protection Rights

You may exercise your rights by contacting Us using the email address below. Please note that we may ask you to verify your identity before responding to such requests. If you make a request, we will try our best to respond to you as soon as possible.

You have the right to complain to a Data Protection Authority about Our collection and use of your Personal Data, namely the Office of Personal Data Protection of the Slovak Republic, Hraničná 12 820 07 Bratislava 27 Slovak Republic, E-mail: statny.dozor@pdp.gov.sk.

Governance, customization & configuration

Align the platform to your protocols — without a custom software project.

Configure escalation thresholds, roles, and reporting to match local pathway rules — while maintaining system-wide governance and consistency.

  • Configurable triggers, roles, and escalation workflows
  • Custom dashboards and views aligned to leadership needs
  • Controlled expansion to additional pathways over time

Outcomes, QA & performance intelligence​

Measure what matters — across every pathway, every site.

Turn pathway execution into dashboards and reporting that help leadership reduce variation, optimize time-to-treatment, and demonstrate value across every deployed suite.

  • Cross-site, cross-pathway, and team-level benchmarking
  • Time-to-treatment and pathway quality tracking
  • QA workflows, audit trails, and leadership reporting
  • Registry-aligned reporting support (NCDR Chest Pain-MI, AHA GWTG, and more)

Escalation & care coordination

Real-time routing that matches how your system actually runs.

Route critical cases to the right team with role-based notifications, escalation logic, and shared case context — across EMS, ED, cardiology, cath lab, and inpatient care.

  • Role-based alerting and escalation across departments and sites
  • Shared case context so receiving teams have what they need before the patient arrives
  • Integration with existing communication and alerting tools

AI-powered decision support

Clinically validated AI that spans the cardiac care journey.

Run multiple AI models on every recording — acute detection, screening, procedural quantification — with interpretable outputs and case-level explainability.

  • Queen of Hearts™ for STEMI/OMI detection
  • LVsense™ for reduced ejection fraction
  • Culprit Artery Prediction for pre-cath planning
  • Core AI for comprehensive rhythm and conduction analysis
  • Expanding model portfolio across Echo Screening, Remote Monitoring, and Angio Suites

Interoperability & deployment

Connect across your existing systems — without replacing them.

Ingest pathway-critical inputs from across your network and IT landscape, and deliver results where teams already work. Built for system-wide rollout with enterprise deployment patterns.

  • Connect to ECG devices, angiographic systems, and ambulatory monitors across sites
  • Launch PMcardio from the EHR / CVIS with secure links and SSO
  • Send results back to clinical systems where care is documented

All Supported ECG Findings

Rhythms
Sinus bradycardia • Sinus rhythm • Sinus tachycardia • Paced rhythm • Atrial fibrillation
Atrial fibrillation with rapid ventricular response • Atrial fibrillation with slow ventricular response • Atrial flutter • Atrial flutter with rapid ventricular response • Atrial flutter with slow ventricular response • Supraventricular tachycardia • Suspected junctional rhythm • Suspected junctional bradycardia • Suspected accelerated junctional rhythm • Wide QRS rhythm • Idioventricular rhythm • Wide QRS tachycardia

Myocardial Infarctions
  • STEMI
  • STEMI
    Equivalent
Detects occlusive myocardial infarctions (OMIs) even without ST elevation (i.e. posterior STEMI, hyperacute T-waves, etc.). Negative for STEMI mimics (i.e. early repolarization, LVH, etc.)
  • High-Risk NSTEMI
    Represents a type 1 myocardial infarction caused by a transiently recanalized coronary occlusion—classically seen in patterns such as Wellens type A or B due to subtotal LAD obstruction, but possible in any infarct-related territory.
  • Culprit Detection
    AI-predicted likelihood scores for LAD, LCx, and RCA with 3D heart visualization highlighting the predicted culprit artery.

Conduction Abnormalities (Heart Blocks
1st degree AV block • 2nd degree AV block, type Wenckebach • Higher degree AV block • Complete right bundle branch block • Incomplete right bundle branch block • Complete left bundle branch block • Incomplete left bundle branch block • Nonspecific intraventricular conduction delay • Left anterior fascicular block • Left posterior fascicular block • Bifascicular block (RBBB + LAFB) • Bifascicular block (RBBB + LPFB) • Trifascicular block (RBBB + LAFB + AVBLOCK1) • Trifascicular block (RBBB + LPFB + AVBLOCK1)

LVEF
Reduced LVEF (≤40%) • Mildly reduced LVEF (41 – 49%) • No signs of reduced LVEF (≥50%)

Axis
Left cardiac axis deviation • Right cardiac axis deviation • Extreme cardiac axis deviation • Normal axis

Measurements
Heart rate • P wave • PR interval • QRS duration • QT interval • Corrected QT interval (Framingham formula) • RR interval • PP interval • ST elevations

Other Supported Diagnoses
Suspected long QT syndrome • Suspected short QT syndrome • Suspected atrial enlargement • Suspected ventricular hypertrophy • Premature complexes

Dr. Tom De Potter, MD

Cardiologist at the Cardiac Center Aalst

Cardiologist specializing in Pacemaker Device Therapy and Electrophysiology. Leads the electrophysiology unit at the Heart Center in Aalst, holds an executive board position at the European Heart Academy, and serves as EHRA scientific program committee co-chair.

Dr. Martin Penicka, MD, PhD

Cardiologist at the Cardiac Center Aalst

Cardiologist at the Cardiac Center Aalst since 2009, specializing in non-invasive imaging and valvular disease. Fellow of the European Society of Cardiology (FESC) and the European Association of Cardiovascular Imaging (FEACVI).

Dr. Ward Heggermont, MD, PhD

Co-director at the Cardiovascular Center

Co-director at the Cardiovascular Center of Aalst Hospital, specializing in heart failure. Research focus at the intersection of cardiology, virology, and metabolism.

Prof. Dr. Robert Hatala, PhD

Co-founder and Chief Scientist

Head of the Arrhythmia and Pacing department at the National Institute of Cardiovascular Diseases in Slovakia. More than 150 publications and 10,000 citations. Contributor to ESC clinical practice guidelines and executive editor of the European Heart Journal since 2020.

Arieh Levy

Head of PMcardio for Individuals

Arieh leads the PMcardio for Individuals product at Powerful Medical, guiding its development as a clinical tool for emergency physicians, cardiologists, and primary care physicians. He holds a First Class MEng in Biomedical Engineering from Imperial College London, where he specialised in AI for cardiology, building physics-informed neural networks to model atrial electrical properties, giving him a background that bridges the clinical and technical demands of building a certified AI medical device used at the bedside every day.

Dr. Dave Pearson, MD​

Business Advisor

Academic emergency medicine physician, entrepreneur, investor, and researcher with nearly two decades at Atrium Health, one of US largest health systems. Brings expertise at the intersection of clinical care, healthcare innovation, and strategic leadership.

Prof. Stephen W. Smith, MD

Professor of Emergency Medicine

Faculty physician in Emergency Medicine at Hennepin County Medical Center and Professor of Emergency Medicine at the University of Minnesota. Co-inventor of the OMI paradigm and editor of Dr. Smith’s ECG Blog, the most-visited US-based ECG interpretation blog.

Prof. Emanuele Barbato, MD, PhD

President of EAPCI

Interventional cardiologist specializing in coronary artery disease and coronary physiology. Acting president of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and contributor to the clinical practice guidelines for STEMI care.

Scott Sharkey, MD

Chief Medical Officer

Chief Medical Officer of the Minneapolis Heart Institute Foundation and practicing cardiologist at Allina Health Minneapolis Heart Institute. Co-founder of the STEMI Midwest consortium and Takotsubo cardiomyopathy research program and a widely published clinical investigator in STEMI care.

Prof. Dr. Leor Perl, MD

Director of Cardiac Catheterization Institute

Director of Complex Cardiac Interventions and Chief Innovation Officer at Rabin Medical Center. Graduate of the Stanford Biodesign Program.

Suzanne J. Baron, MD, MSc

Director of Interventional Cardiology Research

Director of Interventional Cardiology Research at Massachusetts General Hospital. Holds a Master’s degree in health economics from Harvard School of Public Health. Expert in cardiovascular device impact on healthcare costs and patient-reported outcomes.

Prof. Marco Valgimigli, MD

Deputy Chief Cardiocentro Ticino Institute

Head of Cardiology at Cardiocentro Ticino and Principal Investigator of the TITAN-OMI randomized controlled trial. His research has shaped both European and US clinical practice guidelines on coronary stents, antithrombotic therapy, and vascular access.

Timothy D. Henry, MD

Medical Director of The Carl and Edyth Lindner Center

Leading expert in interventional cardiology and STEMI treatment. Co-founder and principal investigator of the Midwest STEMI Consortium, a registry of more than 20,000 consecutive STEMI activations. Presenting author for the TCT 2025 Late-Breaking Clinical Science on Queen of Hearts.

Matus Horvath

Head of People

Matus leads hiring strategy and culture at Powerful Medical. He previously ran the People Team at Slido, the Slovak SaaS startup later acquired by Cisco — an experience that informs how he builds a high-performing, values-driven team through rapid scaling.

Dr. Timea Kisova, MD

Clinical Research Lead

Timea leads Powerful Medical’s global external validation studies, including the multi-country AI ECG TIMI Study. With a background in biomedical sciences and a medical degree from Barts and The London School of Medicine and Dentistry, she brings the clinical discipline required to generate the prospective, real-world evidence behind every PMcardio module.

Dr. Anthony Demolder, MD, PhD

HF Pathway Lead

Research physician with a PhD on arrhythmias in heritable thoracic aortic disease. He has led international studies at the intersection of cardiology and AI — including earlier work on atrial fibrillation at AZ Sint-Jan Brugge — and now drives Powerful Medical’s heart failure pathway and LVsense™ AI model development.

Dr. Pendell Meyers, MD

ACS Pathway Lead

Emergency medicine physician, prolific educator, and Co-Editor of Dr. Smith’s ECG Blog. He is one of the leading voices behind the Occlusion Myocardial Infarction (OMI) paradigm, the clinical framework that reshaped how heart attacks are identified from the ECG — and which sits at the core of the Queen of Hearts™ model.

Adam Dej

Head of PMcardio for Organizations Engineering

Adam leads engineering for PMcardio for Organizations at Powerful Medical, driving platform architecture, backend systems, and infrastructure behind one of the company’s key growth products. He began programming at 13, entered professional IT at 17, and studied computer security at Comenius University’s Faculty of Mathematics, Physics and Informatics. Known for technical depth across distributed systems, infrastructure, and security, he builds scalable and resilient software with a sharp focus on customer impact. He also champions responsible use of AI and LLMs as force multipliers for modern engineering teams.

Gabriela Rovder Sklencarova

Head of Infrastructure

Gabriela designs the scalable, secure, distributed systems that keep PMcardio running around the clock for clinicians worldwide. She joined from Google, where she was a senior software engineer building core libraries that kept Google’s services resilient against billions of requests, and holds a BA and MA in Computer Science from the University of Cambridge.

Arezou Azar

US and Global Regulatory

Arezou leads Powerful Medical’s global regulatory strategy across the FDA, EU MDR, and international frameworks. She has been part of nearly every major breakthrough in AI cardiology and is an expert in US and global regulatory strategy, SaMD/digital health launches, with experience at Eko Health, Verily, AliveCor, Cardiologs, and Apple. She specializes in regulatory strategy in high-paced global organizations.

Adam Rafajdus

Head of AI

Adam grew into the Head of AI role from MLOps Engineer over six years at Powerful Medical, bringing deep expertise in deep learning and production-grade system deployment. He leads the team behind the Queen of Hearts™ AI ECG models and was awarded Best Poster at ISCE 2025 for the company’s ECG digitization pipeline.

Mike Wall

VP of Sales

Mike brings more than twenty years at UnitedHealth Group to the table, where he served health plans, employer groups, and public-sector entities as a consultative healthcare sales executive. He combines market intelligence, clinical insight, and financial acumen — the three ingredients needed to bring AI-powered diagnostics into US health systems at scale.

Amani Farid

Head of Strategic Partnerships

Amani leads partnership strategy with a hands-on approach to integration, unlocking long-term value through collaboration and scale. A University of Chicago Law School-trained attorney and former M&A and capital markets associate at two top international law firms, she brings the rare combination of legal precision and commercial execution refined across nearly a decade at Stryker and as VP of Corporate Development at RapidAI — spanning medtech, digital health, and AI-driven diagnostics.

Michal Martonak

Commercial Lead

A mathematician by training, Michal leads commercial strategy, go-to-market, and strategic partnerships with healthcare providers and clinical institutions worldwide. He previously built Powerful Medical’s data and clinical partnerships function, acquiring the large-scale clinical datasets that underpin the company’s certified AI models.

Dr. Jozef Bartunek, MD, PhD

Co-founder and VP Clinical Strategy

Interventional cardiologist and Co-director of the Cardiovascular Center in Aalst, Belgium — one of the world’s leading heart centers. A Fogarty International NIH Fellow at Harvard Medical School and visiting Professor of Medicine at Catholic University Leuven, he has authored more than 240 peer-reviewed publications in heart failure and structural heart disease, and anchors Powerful Medical’s clinical and research strategy.

Simon Rovder

Co-founder and CTO

Simon began his engineering career at Microsoft and holds a Master’s degree in Informatics from the University of Edinburgh. He built and scaled Powerful Medical’s technology organization from the ground up to a team of 20+ engineers, leading the architecture of a CE-certified Class IIb medical device now deployed in hospitals across Europe.

Viktor Jurasek

Co-founder and CPO

Viktor was modding computer games before his teens and has spent the last decade shipping digital products across advertising, finance, and healthcare. As co-founder and CPO, he has led PMcardio’s product and design since the first prototype, setting the bar for how a clinical-grade tool should feel in a physician’s hands — fast, clear, and trustworthy at the point of care.

Felix Bauer

Co-founder and COO

Felix was part of the Hyperloop team that repeatedly competed and won in Elon Musk’s SpaceX Hyperloop Pod Competition. He holds a degree from the Technical University of Munich and brings a rare combination of engineering rigor, regulatory discipline, and operational excellence to the company, spearheading operations, compliance, regulatory, quality management, and global market access since day one.

Dr. Robert Herman, MD, PhD

Co-founder and Chief Medical Officer

Robert is a physician-scientist who served on the Research, Digital and Innovation Committee of the European Society of Cardiology. He bridges medicine and AI, connecting clinicians, researchers, regulators, and trial leaders to translate algorithms into clinical practice. He founded multiple AI ECG models, leads international clinical trials validating them, is a recipient of the Journal of the American College of Cardiology Spencer King Award, and was named to Forbes 30 Under 30 Europe 2024.

Martin Herman

Co-founder and CEO

Martin started coding at 14 and moved to Silicon Valley at 18, founding several companies including a US-based startup before returning to Europe with his brother Robert to build Powerful Medical. He comes from a family of doctors, which shaped his conviction that AI belongs wherever it can genuinely save lives. Forbes 30 Under 30 (Europe 2024).

Heart Attacks are #1 cause of death world-wide and killing about 12 milions people a year.

Clinical Definition of Problem

Contrary to popular belief, a heart attacks isn’t a blockage inside of the heart. A heart attack is a blockage of the coronary arteries supplying the heart muscle with oxygenated blood.

So let’s assume you get a blood clot here — it blocks the blood flow downstream, meaning the heart muscle doesn’t get oxygenated blood and heart tissue downstream starts to die.

Clinical Solution​

The way to fix it is relatively simple – doctors put in a stent that opens up the artery and renews blood flow. The latest clinical practice guidelines recommend that this “stenting” happens within 90 minutes from symptom onset.

If you don’t, even if you put in the stent in later, the heart tissue downstream has already been permanently damaged, which reduces the heart’s ability to pump blood. This is the leading cause of heart failure and increases 1-year mortality by two-fold.

Time is muscle.

You have just 90 minutes to diagnose the patient, bring them to the hospital and put in the stent, otherwise there is permanent damage. So problem is, that 1 in 2 heart attacks get initially misdiagnosed at the first point of contact.

Discover the future of medical work with us.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.